Could A Daily Supplement Keep Blood Vessels Healthier As We Age?
A small randomized trial found improved vessel-function measures and lower systolic blood pressure after six months, but did not test cardiovascular events.
Safety Of Controversial Vasculitis Drug Bolstered In Dedicated Trial
Interim AvacoStar results found more liver abnormalities with avacopan, but rates were low and other serious events were not higher than with alternatives.